Disclosing pleiotropic effects during genetic risk assessment for Alzheimer’s Disease: A randomized trial

Christensen KD, Roberts JS, Whitehouse PJ, Royal CDM, Obisesan TO, Cupples LA, Vernarelli JA, Bhatt DL, Linnenbringer E, Butson MB, Fasaye G-A, Uhlmann WR, Hiraki S, Cook-Deegan R, Green RC, for the REVEAL Study Group.
Annals of Internal Medicine February 2016